medic dilantin phenobarbit propofol zofran introduct continu eeg perform bedsid icu use standard 10-20 system electrod placement one channel ekg start time ltm 13 44 descript record background eeg demonstr overal transit becom increas lower voltag more discontinu transform burst activ follow burst attenu lower voltag record comment regard pentobarbit initi 15 02 39 preced paroxysm chang describ abov 20 56 again phenobarbit bolus given comment integr record demonstr increas burst suppression-lik pattern midnight eeg mark suppress intermitt burst activ essenti bilater vecuronium given 21 26th long-term eeg monitor august 26 2006 august 27 2006 introduct continu eeg perform bedsid icu use standard 10-20 system electrod placement one channel ekg addit note regard dose pentobarbit until much later 00 pentobarbit dose point discontinu restart reason entir clear descript record eeg mark suppress cerebr activ alpha frequenc artifact pick up background particular invari henc unlik cerebr origin addit comment regard pentobarbit drip long-term eeg monitor august 27 2006 august 28 2006 descript record background eeg mark suppress ekg lead discern eeg read sensit scant veri low voltag activ background eeg longer paroxysm burst hr 108 bpm long-term eeg monitor august 28 2006 august 29 2006 descript record eeg monitor time identifi entir suppress pattern progress low voltag suppress background artifact hr 120 bpm impress eeg monitor patient remark initi intrahemispher asymmetri follow appear burst suppress pattern pentobarbit therapi follow mark low voltag suppress pattern clinic correl eeg support sever disturb cerebr function affect right hemispher more left well pharmacolog effect pentobarbit addit histori provid indic happen later day record regard ongo use versus cessat pentobarbit report craniotomi impact result further inform need addit clinic inform necessari